First Tracks Biotherapeutics, Inc. (TRAX) Reports Q2 Loss of $0.95

First Tracks Biotherapeutics, Inc. (NASDAQ: TRAX) reported Q2 EPS of ($0.95).

For earnings history and earnings-related data on First Tracks Biotherapeutics, Inc. (TRAX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
• First Tracks Biotherapeutics (TRAX) PT Raised to $95 at Piper Sandler